Incidence of acute otitis media in children < 16 years old in Germany during 2014-2019.
Acute otitis media
Complications
Healthcare claims
Pneumococcal conjugate vaccine
Recurrent AOM
Surgical procedures
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
13 04 2022
13 04 2022
Historique:
received:
31
08
2021
accepted:
28
03
2022
entrez:
14
4
2022
pubmed:
15
4
2022
medline:
16
4
2022
Statut:
epublish
Résumé
Acute otitis media (AOM) remains a common infection in children despite the introduction of pneumococcal conjugate vaccines. This study estimated AOM incidence rates (IRs) over time in children < 16 years old in Germany following PCV13 introduction. AOM episodes were identified in the InGef healthcare claims database from 2014-2019 in children aged < 16 years. Each AOM episode was classified as either simple or recurrent. Recurrent AOM was defined as 3 or more episodes identified within a 6-month period; or 4 or more episodes within a 12-month period with at least one episode in the prior 6 months. AOM-related surgical procedures within 12 months and complications within 21 days of an AOM episode were also identified. Annual IRs were calculated as number of episodes/child-years (CY) at risk. 95% Confidence intervals (95%CI) were calculated using the Wilson method. The Mann-Kendall test was used to assess trends over time. Between 2014 and 2019, the study population comprised 916,805 children with 327,726 AOM episodes, of which 15% (49,011) of all episodes were identified as recurrent AOM and 85% (278,715) as simple AOM. There were significant declines in AOM (p = 0.003) in the study population overall and in all age groups over the study period; from 101 (95%CI 101-102)/1000 CY to 79 (95%CI 78-80)/1000 CY in the total study population, from 209 (95%CI 206-212)/1000 CY to 147 (95%CI 145-150)/1000 CY in < 2-year-olds, from 239 (95%CI 237-242) to 179 (95%CI 177-182)/1000 CY in 2-4-year-olds, and from 50 (95%CI 49-50) to 38 (95%CI 37-39)/1000 CY in 5-15-year-olds. No significant trends were identified for AOM-related surgical procedures over the study period; however, AOM-related complications overall increased (p = 0.003). Between 2014 and 2019, AOM incidence overall declined in children aged 0-15 years in Germany. Over the study period, the incidence of complicated AOM cases increased, however the incidence of AOM-related surgical procedures remained constant. Despite the impact of PCV13, the burden associated with AOM in Germany remains substantial.
Sections du résumé
BACKGROUND
Acute otitis media (AOM) remains a common infection in children despite the introduction of pneumococcal conjugate vaccines. This study estimated AOM incidence rates (IRs) over time in children < 16 years old in Germany following PCV13 introduction.
METHODS
AOM episodes were identified in the InGef healthcare claims database from 2014-2019 in children aged < 16 years. Each AOM episode was classified as either simple or recurrent. Recurrent AOM was defined as 3 or more episodes identified within a 6-month period; or 4 or more episodes within a 12-month period with at least one episode in the prior 6 months. AOM-related surgical procedures within 12 months and complications within 21 days of an AOM episode were also identified. Annual IRs were calculated as number of episodes/child-years (CY) at risk. 95% Confidence intervals (95%CI) were calculated using the Wilson method. The Mann-Kendall test was used to assess trends over time.
RESULTS
Between 2014 and 2019, the study population comprised 916,805 children with 327,726 AOM episodes, of which 15% (49,011) of all episodes were identified as recurrent AOM and 85% (278,715) as simple AOM. There were significant declines in AOM (p = 0.003) in the study population overall and in all age groups over the study period; from 101 (95%CI 101-102)/1000 CY to 79 (95%CI 78-80)/1000 CY in the total study population, from 209 (95%CI 206-212)/1000 CY to 147 (95%CI 145-150)/1000 CY in < 2-year-olds, from 239 (95%CI 237-242) to 179 (95%CI 177-182)/1000 CY in 2-4-year-olds, and from 50 (95%CI 49-50) to 38 (95%CI 37-39)/1000 CY in 5-15-year-olds. No significant trends were identified for AOM-related surgical procedures over the study period; however, AOM-related complications overall increased (p = 0.003).
CONCLUSION
Between 2014 and 2019, AOM incidence overall declined in children aged 0-15 years in Germany. Over the study period, the incidence of complicated AOM cases increased, however the incidence of AOM-related surgical procedures remained constant. Despite the impact of PCV13, the burden associated with AOM in Germany remains substantial.
Identifiants
pubmed: 35418046
doi: 10.1186/s12887-022-03270-w
pii: 10.1186/s12887-022-03270-w
pmc: PMC9006409
doi:
Substances chimiques
Pneumococcal Vaccines
0
Vaccines, Conjugate
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
204Informations de copyright
© 2022. The Author(s).
Références
Pediatr Infect Dis J. 2014 May;33(5):453-7
pubmed: 24732389
Ear Nose Throat J. 2021 Jun;100(3_suppl):325S-332S
pubmed: 32579395
J Antimicrob Chemother. 2004 Feb;53(2):361-6
pubmed: 14729760
Epidemiol Infect. 2014 Aug;142(8):1778-88
pubmed: 24330917
J Antimicrob Chemother. 2021 Aug 12;76(9):2419-2427
pubmed: 34021757
Pediatr Infect Dis J. 2020 Aug;39(8):763-770
pubmed: 32639460
Arch Otolaryngol Head Neck Surg. 2009 Jul;135(7):638-41
pubmed: 19620582
Nat Rev Dis Primers. 2016 Sep 08;2:16063
pubmed: 27604644
BMC Infect Dis. 2012 Nov 20;12:312
pubmed: 23167692
Pediatrics. 2017 Sep;140(3):
pubmed: 28784702
BMC Health Serv Res. 2018 May 2;18(1):318
pubmed: 29720156
J Laryngol Otol. 2013 Jan;127 Suppl 1:S30-4
pubmed: 23186827
Otolaryngol Clin North Am. 1991 Aug;24(4):757-61
pubmed: 1870869
BMC Infect Dis. 2015 May 05;15:207
pubmed: 25940580
JAMA Pediatr. 2014 Jan;168(1):68-75
pubmed: 24276262
Dtsch Arztebl Int. 2014 Feb 28;111(9):151-9; quiz 160
pubmed: 24661591
BMC Health Serv Res. 2021 Mar 4;21(1):193
pubmed: 33663491
Epidemiol Infect. 1998 Dec;121(3):529-34
pubmed: 10030701
Vaccine. 2010 Nov 19;28 Suppl 6:G39-52
pubmed: 21075269
BMC Infect Dis. 2016 Aug 11;16(1):407
pubmed: 27514843
BMC Health Serv Res. 2018 Sep 14;18(1):715
pubmed: 30217156
Expert Rev Anti Infect Ther. 2014 Sep;12(9):1159-63
pubmed: 25075863
Pharmacoepidemiol Drug Saf. 2016 Jan;25(1):106-9
pubmed: 26530279
Pediatr Infect Dis J. 2017 Mar;36(3):274-281
pubmed: 27918383
Otolaryngol Head Neck Surg. 2017 May;156(5):938-945
pubmed: 28349737
Eur J Pediatr. 2015 Mar;174(3):355-64
pubmed: 25169065
Int J Pediatr Otorhinolaryngol. 2017 Oct;101:249-253
pubmed: 28964304
J Infect Dis. 1989 Jul;160(1):83-94
pubmed: 2732519
BMC Pediatr. 2012 Nov 29;12:185
pubmed: 23190626
BMC Pediatr. 2016 Jul 26;16:108
pubmed: 27457584
Clin Vaccine Immunol. 2014 Aug;21(8):1189-91
pubmed: 24920600
BMC Med. 2014 Jun 26;12:107
pubmed: 24965189
J Pediatr. 2021 Aug;235:233-238.e3
pubmed: 33894263
Otol Neurotol. 2018 Sep;39(8):1005-1011
pubmed: 30113560
Eur J Clin Microbiol Infect Dis. 2010 Jul;29(7):749-54
pubmed: 20432051
Front Med (Lausanne). 2021 May 20;8:675225
pubmed: 34095179
An Pediatr (Barc). 2004 Nov;61(5):408-12
pubmed: 15530320
Hum Vaccin Immunother. 2022 Dec 31;18(1):1942712
pubmed: 34319865
Pediatr Infect Dis J. 2017 Nov;36(11):1027-1031
pubmed: 28657970
J Med Microbiol. 2015 Oct;64(10):1103-1116
pubmed: 26248613
Int J Pediatr Otorhinolaryngol. 2014 Oct;78(10):1599-604
pubmed: 25074345
Acta Biomed. 2020 Feb 17;91(1-S):54-59
pubmed: 32073562
BMJ Open. 2020 May 5;10(5):e035343
pubmed: 32371515